Sign in
4

Changes in Ownership

Corvus Pharmaceuticals, Inc. Filed Acc 0001209191-16-111003

10% owner bought 666,666 shares at $15.00 ($9,999,990)

  • 10% owner acquired 2,487,380 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Novo A/S · 10% owner

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2016-03-29 Conversion : show line 1 in the form +2,130,492 2,130,492 D
2016-03-29 Conversion : show line 2 in the form +356,888 2,487,380 D
2016-03-29 Purchase : show line 3 in the form +666,666 $15.00 $9,999,990 3,154,046 D
Open-market purchases · 666,666 sh · avg $15.00 · $9,999,990

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2016-03-29 Conversion : show line 4 in the form Series A Preferred Stock −2,130,492 0 D
2016-03-29 Conversion : show line 5 in the form Series B Preferred Stock −356,888 0 D
Loading xslF345X03/doc4.xml…